159 related articles for article (PubMed ID: 31686345)
1. ASO Author Reflections: Major Morbidity After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies.
Peacock O; Waters PS; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):415-416. PubMed ID: 31686345
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Pelvic Exenteration for Patients with Primary and Recurrent Pelvic Cancer.
Kulu Y
Ann Surg Oncol; 2019 May; 26(5):1350. PubMed ID: 30843159
[No Abstract] [Full Text] [Related]
3. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
[TBL] [Abstract][Full Text] [Related]
4. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
5. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
Kolbert G; Müller G; Kujath P; Bruch HP
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
[TBL] [Abstract][Full Text] [Related]
6. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
7. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
[TBL] [Abstract][Full Text] [Related]
8. The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors.
D'Addato F; Guercio E; Re A; Gatti M; Raspollini M; Proserpio D; Bellino R; Lanza A
Eur J Gynaecol Oncol; 1988; 9(5):420-3. PubMed ID: 3224613
[TBL] [Abstract][Full Text] [Related]
9. Total pelvic exenteration with preservation of fecal continence.
Brodsky JT; Sloane BB; Khanna OP
J Surg Oncol; 1993 Aug; 53(4):261-4. PubMed ID: 8341059
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration for advanced pelvic malignancies.
Yu HH; Leong CH; Ong GB
Aust N Z J Surg; 1976 Aug; 46(3):197-201. PubMed ID: 1070292
[TBL] [Abstract][Full Text] [Related]
12. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
13. Anatomical approaches in locally advanced and recurrent pelvic malignancy.
Collins D; Jones R; Griffiths B
Eur J Surg Oncol; 2022 Nov; 48(11):2258-2262. PubMed ID: 35086682
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration and its modifications.
Rodriguwz-Bigas MA; Petrelli NJ
Am J Surg; 1996 Feb; 171(2):293-8. PubMed ID: 8619471
[TBL] [Abstract][Full Text] [Related]
15. Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.
Bacalbasa N; Balescu I; Vilcu M; Neacsu A; Dima S; Croitoru A; Brezean I
In Vivo; 2019; 33(6):2205-2210. PubMed ID: 31662557
[TBL] [Abstract][Full Text] [Related]
16. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.
Kong JC; Peacock O; Waters PS; Eglinton T; Warrier SK; Wakeman C; Frizelle FA; Heriot AG; McCormick JJ
Langenbecks Arch Surg; 2020 Jun; 405(4):491-502. PubMed ID: 32533361
[TBL] [Abstract][Full Text] [Related]
17. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of fluorescent ureteral navigation in total pelvic exenteration using a two-team approach for locally recurrent pelvic malignancies-A video vignette.
Ogura A; Murata Y; Jinno T; Yoshikawa N; Kajiyama H; Ebata T
Colorectal Dis; 2024 Apr; 26(4):812-813. PubMed ID: 38326712
[No Abstract] [Full Text] [Related]
19. Sacral resection for control of pelvic tumors.
Temple WJ; Ketcham AS
Am J Surg; 1992 Apr; 163(4):370-4. PubMed ID: 1373043
[TBL] [Abstract][Full Text] [Related]
20. Management of advanced pelvic cancer by exenteration.
Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
